把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| — |
| -$30.17M |
| — |
| — |
| — |
| 115 |
| 尚无授权文本 |
| CLB Core Laboratories Inc. /DE/ | 2026-06-30 | 3/3 | $124.61M | $5.96M | $3.64M | 18.6% | 7.3% | 35 | 尚无授权文本 |
| GOOG Alphabet Inc. | 2026-06-30 | 3/3 | $119.8B | $112.19B | $4.26B | 61.6% | 34.0% | 54 | 尚无授权文本 |
| GOOGL Alphabet Inc. | 2026-06-30 | 3/3 | $119.8B | $112.19B | $4.26B | 61.6% | 34.0% | 54 | 尚无授权文本 |
| GOVX GeoVax Labs, Inc. | 2026-06-30 | 3/3 | — | -$4.43M | -$7.2M | — | — | 109 | 尚无授权文本 |
| NBR NABORS INDUSTRIES LTD | 2026-06-30 | 3/3 | $814.8M | -$22.33M | -$41.99M | — | 13.6% | 108 | 尚无授权文本 |
| PRLB Proto Labs Inc | 2026-06-30 | 3/3 | — | $9.15M | $23.24M | — | — | 73 | 尚无授权文本 |
| SDEV Stablecoin Development Corp | 2026-06-30 | 3/3 | — | -$41.07M | — | — | — | 107 | 尚无授权文本 |
| WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | 2026-06-30 | 3/3 | $3.18B | $395M | $532M | 36.5% | 18.9% | 91 | 尚无授权文本 |
| DLB Dolby Laboratories, Inc. | 2026-06-26 | 3/3 | $305M | $28.6M | $286.09M | 86.8% | 11.3% | 66 | 尚无授权文本 |
| JBL JABIL INC | 2026-05-31 | 3/3 | $8.75B | $275M | $887M | 9.5% | 5.1% | 85 | 尚无授权文本 |
| PLAB PHOTRONICS INC | 2026-05-03 | 3/3 | $209.94M | $31.43M | $50.85M | 31.3% | 20.1% | 76 | 尚无授权文本 |
| ANF ABERCROMBIE & FITCH CO /DE/ | 2026-05-02 | 3/3 | $1.11B | $67.13M | -$17.09M | 62.8% | 8.0% | 81 | 尚无授权文本 |
| ABM ABM INDUSTRIES INC /DE/ | 2026-04-30 | 3/3 | $2.29B | $43.1M | $71.2M | 12.1% | 3.8% | 71 | 尚无授权文本 |
| GTLB Gitlab Inc. | 2026-04-30 | 3/3 | $264.16M | -$4.97M | $146.8M | 85.8% | -6.0% | 59 | 尚无授权文本 |
| MSB MESABI TRUST | 2026-04-30 | 3/3 | $2.25M | $1.09M | — | 48.4% | — | 80 | 尚无授权文本 |
| OCC OPTICAL CABLE CORP | 2026-04-30 | 3/3 | — | $1.05M | -$1.57M | — | — | 65 | 尚无授权文本 |
| PL Planet Labs PBC | 2026-04-30 | 3/3 | $94.15M | -$138.87M | -$1.87M | 53.5% | -37.1% | 77 | 尚无授权文本 |
| SEB SEABOARD CORP /DE/ | 2026-04-04 | 3/3 | $2.4B | $120M | -$150M | 9.0% | 4.0% | 63 | 尚无授权文本 |
| SLAB SILICON LABORATORIES INC. | 2026-04-04 | 3/3 | $213.5M | -$15.9M | -$4.9M | 59.5% | -8.0% | 84 | 尚无授权文本 |
| ESAB ESAB Corp | 2026-04-03 | 3/3 | $745.6M | $47.64M | $33.21M | 36.9% | 12.1% | 57 | 尚无授权文本 |
| AACO Abony Acquisition Corp. I | 2026-03-31 | 3/3 | — | $546,079 | — | — | — | 5 | 尚无授权文本 |
| AACOU Abony Acquisition Corp. I | 2026-03-31 | 3/3 | — | $546,079 | — | — | — | 5 | 尚无授权文本 |
| ABAT AMERICAN BATTERY TECHNOLOGY Co | 2026-03-31 | 3/3 | $7.81M | -$33.84M | — | 9.4% | -440.5% | 124 | 尚无授权文本 |
| ABBV AbbVie Inc. | 2026-03-31 | 3/3 | $15B | $695M | $3.56B | 71.9% | 26.6% | 110 | 尚无授权文本 |
| ABCB Ameris Bancorp | 2026-03-31 | 3/3 | — | $110.49M | $249.41M | — | — | 71 | 尚无授权文本 |
| ABCL AbCellera Biologics Inc. | 2026-03-31 | 3/3 | $8.32M | -$43.17M | -$37.35M | — | -691.7% | 80 | 尚无授权文本 |
| ABEO ABEONA THERAPEUTICS INC. | 2026-03-31 | 3/3 | $8.72M | -$17.08M | -$20.74M | 69.1% | -264.1% | 111 | 尚无授权文本 |
| ABNB Airbnb, Inc. | 2026-03-31 | 3/3 | $2.68B | $160M | — | 78.3% | 3.2% | 38 | 尚无授权文本 |
| ABOS Acumen Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$20.74M | — | — | — | 72 | 尚无授权文本 |
| ABSI Absci Corp | 2026-03-31 | 3/3 | — | -$29.6M | -$26.34M | — | — | 75 | 尚无授权文本 |
| ABT ABBOTT LABORATORIES | 2026-03-31 | 3/3 | $11.16B | $1.08B | $916M | 56.2% | 12.0% | 80 | 尚无授权文本 |
| ABTC American Bitcoin Corp. | 2026-03-31 | 3/3 | $62.12M | -$81.79M | — | 52.4% | -190.3% | 168 | 尚无授权文本 |
| ABUS Arbutus Biopharma Corp | 2026-03-31 | 3/3 | $179.13M | $169.7M | — | — | 94.3% | 139 | 尚无授权文本 |
| ABVC ABVC BIOPHARMA, INC. | 2026-03-31 | 3/3 | — | -$1.56M | — | — | — | 99 | 尚无授权文本 |
| ABX Abacus Global Management, Inc. | 2026-03-31 | 3/3 | $59.39M | $7.27M | $91.55M | 89.4% | 30.9% | 113 | 尚无授权文本 |
| ABXL Abacus Global Management, Inc. | 2026-03-31 | 3/3 | $59.39M | $7.27M | $91.55M | 89.4% | 30.9% | 113 | 尚无授权文本 |
| AGIG ABUNDIA GLOBAL IMPACT GROUP, INC. | 2026-03-31 | 3/3 | $132,965 | -$5.23M | -$5.43M | — | -3864.3% | 76 | 尚无授权文本 |
| AIDX 20/20 Biolabs, Inc. | 2026-03-31 | 3/3 | $353,375 | -$2.17M | — | 17.8% | -408.4% | 8 | 尚无授权文本 |
| ALAB Astera Labs, Inc. | 2026-03-31 | 3/3 | $308.36M | $80.31M | $67.01M | 76.3% | 20.1% | 29 | 尚无授权文本 |
| ALOV Aldabra 4 Liquidity Opportunity Vehicle, Inc. | 2026-03-31 | 3/3 | — | $1.24M | — | — | — | 4 | 尚无授权文本 |
| ANAB ANAPTYSBIO, INC | 2026-03-31 | 3/3 | $25.56M | -$52.88M | -$25.94M | — | -135.5% | 103 | 尚无授权文本 |
| AQB AQUABOUNTY TECHNOLOGIES INC | 2026-03-31 | 3/3 | — | -$1.2M | — | — | — | 98 | 尚无授权文本 |
| BABA Alibaba Group Holding Ltd | 2026-03-31 | 3/3 | $1,023.67B | $103.59B | — | 39.8% | 4.9% | 255 | 尚无授权文本 |
| BCAB BioAtla, Inc. | 2026-03-31 | 3/3 | — | -$6.34M | — | — | — | 85 | 尚无授权文本 |
| BGLC BioNexus Gene Lab Corp | 2026-03-31 | 3/3 | $22,842 | -$543,575 | -$147,996 | -3.5% | -2366.2% | 70 | 尚无授权文本 |
| BIO BIO-RAD LABORATORIES, INC. | 2026-03-31 | 3/3 | $592.1M | -$527.1M | $78.1M | 52.3% | 5.8% | 80 | 尚无授权文本 |
| BIOA BioAge Labs, Inc. | 2026-03-31 | 3/3 | $2.77M | -$22.25M | -$24.07M | — | -915.4% | 22 | 尚无授权文本 |
| BLND Blend Labs, Inc. | 2026-03-31 | 3/3 | $30.84M | -$8.05M | — | 75.8% | -16.4% | 61 | 尚无授权文本 |
| BTU PEABODY ENERGY CORP | 2026-03-31 | 3/3 | $973.3M | -$32.4M | — | — | -4.5% | 145 | 尚无授权文本 |
| BW Babcock & Wilcox Enterprises, Inc. | 2026-03-31 | 3/3 | $214.41M | -$76.95M | $10.66M | 20.3% | -0.8% | 147 | 尚无授权文本 |
| BWNB Babcock & Wilcox Enterprises, Inc. | 2026-03-31 | 3/3 | $214.41M | -$76.95M | $10.66M | 20.3% | -0.8% | 147 | 尚无授权文本 |
| CABA Cabaletta Bio, Inc. | 2026-03-31 | 3/3 | — | -$43.52M | -$42.56M | — | — | 105 | 尚无授权文本 |
| CABO Cable One, Inc. | 2026-03-31 | 3/3 | — | $35.77M | $49.8M | — | — | 100 | 尚无授权文本 |
| CABR Caring Brands, Inc. | 2026-03-31 | 3/3 | — | -$2.01M | — | — | — | 15 | 尚无授权文本 |
| CBT CABOT CORP | 2026-03-31 | 3/3 | $904M | $68M | $89M | 23.2% | 14.3% | 69 | 尚无授权文本 |
| CGABL Carlyle Group Inc. | 2026-03-31 | 3/3 | $254M | -$132.2M | -$1.27B | — | — | 79 | 尚无授权文本 |
| COAG Hemab Therapeutics Holdings, Inc. | 2026-03-31 | 3/3 | — | -$22.69M | -$21.7M | — | — | 4 | 尚无授权文本 |
| CYAB CYABRA, INC. | 2026-03-31 | 3/3 | $1.42M | -$10.77M | -$2.6M | 86.4% | -835.6% | 7 | 尚无授权文本 |
| ECL ECOLAB INC. | 2026-03-31 | 3/3 | $4.07B | $432.6M | $97.4M | 43.6% | 15.3% | 100 | 尚无授权文本 |
| ELAB PMGC Holdings Inc. | 2026-03-31 | 3/3 | $681,994 | -$4.97M | -$3.34M | 33.8% | — | 106 | 尚无授权文本 |
| EQH Equitable Holdings, Inc. | 2026-03-31 | 3/3 | $4.23B | $621M | — | — | — | 99 | 尚无授权文本 |
| ESTA ESTABLISHMENT LABS HOLDINGS INC. | 2026-03-31 | 3/3 | $59.88M | -$13.38M | -$6.16M | 70.7% | -10.9% | 102 | 尚无授权文本 |
| FABC Fabric.AI, Inc. | 2026-03-31 | 3/3 | — | -$2.41M | — | — | — | 88 | 尚无授权文本 |
| GABC GERMAN AMERICAN BANCORP, INC. | 2026-03-31 | 3/3 | $122.93M | $33.15M | $35.98M | — | — | 107 | 尚无授权文本 |
| GROV Grove Collaborative Holdings, Inc. | 2026-03-31 | 3/3 | $36.22M | -$1.01M | -$977,000 | 54.8% | -2.5% | 85 | 尚无授权文本 |
| HASI HA Sustainable Infrastructure Capital, Inc. | 2026-03-31 | 3/3 | $124.23M | -$71.97M | — | — | — | 122 | 尚无授权文本 |
| IDXX IDEXX LABORATORIES INC /DE | 2026-03-31 | 3/3 | $1.14B | $278.45M | $234.26M | 63.4% | 31.8% | 72 | 尚无授权文本 |
| INAB IN8BIO, INC. | 2026-03-31 | 3/3 | — | -$5.09M | — | — | — | 94 | 尚无授权文本 |
| IRAB Iris Acquisition Corp II | 2026-03-31 | 3/3 | — | $773,935 | — | — | — | 7 | 尚无授权文本 |
| ISBA ISABELLA BANK CORP | 2026-03-31 | 3/3 | — | $4.99M | $3.24M | — | — | 115 | 尚无授权文本 |
| LAB STANDARD BIOTOOLS INC. | 2026-03-31 | 3/3 | $21.15M | $127.07M | -$47.17M | 53.5% | -59.1% | 108 | 尚无授权文本 |
| LABT Lakewood-Amedex Biotherapeutics Inc. | 2026-03-31 | 3/3 | — | -$923,291 | — | — | — | 4 | 尚无授权文本 |
| LH LABCORP HOLDINGS INC. | 2026-03-31 | 3/3 | $3.54B | $277.8M | $70.5M | 28.7% | 10.8% | 159 | 尚无授权文本 |
| LONA LeonaBio, Inc. | 2026-03-31 | 3/3 | — | -$32.95M | — | — | — | 76 | 尚无授权文本 |
| MLAB MESA LABORATORIES INC /CO/ | 2026-03-31 | 3/3 | $249.13M | $6.71M | $39.58M | 63.5% | 7.4% | 83 | 尚无授权文本 |
| MNTK Montauk Renewables, Inc. | 2026-03-31 | 3/3 | $46.43M | $5,000 | -$15.02M | — | -3.4% | 80 | 尚无授权文本 |
| MOBX MOBIX LABS, INC | 2026-03-31 | 3/3 | $970,000 | -$5.85M | — | 19.0% | -627.9% | 86 | 尚无授权文本 |
| NABL N-able, Inc. | 2026-03-31 | 3/3 | $133.68M | -$615,000 | $15.78M | 76.2% | 9.3% | 62 | 尚无授权文本 |
| OABI OmniAb, Inc. | 2026-03-31 | 3/3 | $14.43M | -$7.71M | -$5.08M | — | -54.3% | 59 | 尚无授权文本 |
| PEW GrabAGun Digital Holdings Inc. | 2026-03-31 | 3/3 | $25.93M | -$1.84M | -$2.76M | 10.7% | -10.2% | 14 | 尚无授权文本 |
| QXL QUANTUM X LABS INC. | 2026-03-31 | 3/3 | — | -$605,000 | — | — | — | 64 | 尚无授权文本 |
| RKLB Rocket Lab Corp | 2026-03-31 | 3/3 | $200.35M | -$45.02M | -$77.4M | 38.2% | -27.9% | 107 | 仅元数据 |
| RVP RETRACTABLE TECHNOLOGIES INC | 2026-03-31 | 3/3 | $7.18M | -$4.23M | -$1.37M | -11.7% | -85.9% | 90 | 尚无授权文本 |
| SABR Sabre Corp | 2026-03-31 | 3/3 | $760.33M | $8.01M | — | 55.9% | 15.2% | 125 | 尚无授权文本 |
| SABS SAB Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$18.87M | -$15.25M | — | — | 101 | 尚无授权文本 |
| SBRA Sabra Health Care REIT, Inc. | 2026-03-31 | 3/3 | $116.69M | $40.88M | — | — | — | 99 | 尚无授权文本 |
| SCHW SCHWAB CHARLES CORP | 2026-03-31 | 3/3 | $6.48B | $2.48B | $7.2B | — | — | 86 | 尚无授权文本 |
| SLNG Stabilis Solutions, Inc. | 2026-03-31 | 3/3 | $10.38M | -$4.08M | $7.15M | 3.5% | — | 79 | 尚无授权文本 |
| SOC Sable Offshore Corp. | 2026-03-31 | 3/3 | $1.27M | -$197.03M | — | — | -9343.4% | 102 | 尚无授权文本 |
| STTK Shattuck Labs, Inc. | 2026-03-31 | 3/3 | $0 | -$14.77M | — | — | — | 70 | 尚无授权文本 |
| TBLA Taboola.com Ltd. | 2026-03-31 | 3/3 | $466.4M | $59.07M | $90.28M | 27.8% | 14.9% | 76 | 尚无授权文本 |
| TENB Tenable Holdings, Inc. | 2026-03-31 | 3/3 | $262.06M | $1.41M | $85.38M | 78.4% | 3.3% | 76 | 尚无授权文本 |
| TNDM TANDEM DIABETES CARE INC | 2026-03-31 | 3/3 | $247.22M | -$20.39M | $4.79M | 55.3% | -7.1% | 79 | 尚无授权文本 |
| VABK Virginia National Bankshares Corp | 2026-03-31 | 3/3 | — | $5.26M | $7.04M | — | — | 89 | 尚无授权文本 |
| VIVS VivoSim Labs, INC. | 2026-03-31 | 3/3 | $131,000 | -$13.84M | -$10.83M | 100.0% | -8768.7% | 72 | 尚无授权文本 |
| WABC WESTAMERICA BANCORPORATION | 2026-03-31 | 3/3 | — | $27.36M | $38.72M | — | — | 94 | 尚无授权文本 |
| WNC WABASH NATIONAL Corp | 2026-03-31 | 3/3 | $303.23M | -$45.17M | -$37.08M | -3.5% | -17.3% | 93 | 尚无授权文本 |
| ZLAB Zai Lab Ltd | 2026-03-31 | 3/3 | $95.56M | -$51.02M | -$13.11M | 59.9% | -72.6% | 108 | 尚无授权文本 |
| CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2026-03-28 | 3/3 | $995.83M | -$14.84M | — | — | 12.0% | 84 | 尚无授权文本 |
| FN Fabrinet | 2026-03-27 | 3/3 | $1.21B | $125.21M | $41.12M | 11.9% | 9.9% | 62 | 尚无授权文本 |
| VBNK VersaBank | 2026-01-31 | 2/3 | — | $11.07M | — | — | — | 145 | 尚无授权文本 |
| ABEV AMBEV S.A. | 2025-12-31 | 2/3 | — | $15.99B | — | — | — | 457 | 尚无授权文本 |
| ABLV Able View Global Inc. | 2025-12-31 | 3/3 | $105.2M | $820,018 | $1.17M | 11.3% | -0.5% | 12 | 尚无授权文本 |
| ABTS Abits Group Inc | 2025-12-31 | 3/3 | $9.13M | -$2.87M | -$1.69M | 40.3% | 40.3% | 58 | 尚无授权文本 |
| ABVX Abivax S.A. | 2025-12-31 | 2/3 | — | -$336.1M | — | — | — | 38 | 尚无授权文本 |
| BEP Brookfield Renewable Partners L.P. | 2025-12-31 | 2/3 | — | $712M | — | — | — | 172 | 尚无授权文本 |
| BEPC Brookfield Renewable Corp | 2025-12-31 | 2/3 | — | -$2.34B | — | — | — | 143 | 尚无授权文本 |
| BEPH Brookfield Renewable Partners L.P. | 2025-12-31 | 2/3 | — | $712M | — | — | — | 172 | 尚无授权文本 |
| BEPI Brookfield Renewable Partners L.P. | 2025-12-31 | 2/3 | — | $712M | — | — | — | 172 | 尚无授权文本 |
| BEPJ Brookfield Renewable Partners L.P. | 2025-12-31 | 2/3 | — | $712M | — | — | — | 172 | 尚无授权文本 |
| CMMB Chemomab Therapeutics Ltd. | 2025-12-31 | 3/3 | — | -$9M | -$11.13M | — | — | 83 | 尚无授权文本 |
| ENLT Enlight Renewable Energy Ltd. | 2025-12-31 | 2/3 | — | $160.7M | — | — | — | 86 | 尚无授权文本 |
| GMAB GENMAB A/S | 2025-12-31 | 2/3 | — | $963M | — | — | — | 412 | 尚无授权文本 |
| GRAB Grab Holdings Ltd | 2025-12-31 | 2/3 | — | $200M | — | — | — | 80 | 尚无授权文本 |
| IMCC IM Cannabis Corp. | 2025-12-31 | 2/3 | — | -$11.75M | — | — | — | 239 | 尚无授权文本 |
| NA Nano Labs Ltd | 2025-12-31 | 3/3 | $27.01M | $135.47M | -$15.41M | -147.3% | 264.4% | 92 | 尚无授权文本 |
| NBP NovaBridge Biosciences | 2025-12-31 | 3/3 | — | -$46.27M | — | — | — | 148 | 尚无授权文本 |
| OTLY Oatly Group AB | 2025-12-31 | 2/3 | — | -$153.12M | — | — | — | 88 | 尚无授权文本 |
| RYOJ rYojbaba Co., Ltd. | 2025-12-31 | 3/3 | $9.34M | $119,394 | $688,484 | 26.6% | -8.1% | 15 | 尚无授权文本 |
| SA SEABRIDGE GOLD INC | 2025-12-31 | 2/3 | — | -$53.17M | — | — | — | 211 | 尚无授权文本 |
| WAVE Eco Wave Power Global AB (publ) | 2025-12-31 | 2/3 | — | -$3.72M | — | — | — | 140 | 尚无授权文本 |
| WLDS Wearable Devices Ltd. | 2025-12-31 | 3/3 | $647,000 | -$8.11M | -$6.62M | -22.9% | -1287.8% | 82 | 尚无授权文本 |
| AMX AMERICA MOVIL SAB DE CV/ | 2025-09-30 | 2/3 | — | $24.4B | — | — | — | 127 | 尚无授权文本 |
| ACB AURORA CANNABIS INC | 2025-03-31 | 2/3 | — | $1.59M | — | — | — | 201 | 尚无授权文本 |
| RDY DR REDDYS LABORATORIES LTD | 2025-03-31 | 2/3 | — | $57.25B | — | — | — | 664 | 尚无授权文本 |
| VRAX Virax Biolabs Group Ltd | 2025-03-31 | 2/3 | — | -$6.07M | — | — | — | 74 | 尚无授权文本 |
| APWC ASIA PACIFIC WIRE & CABLE CORP LTD | 2024-12-31 | 2/3 | — | $6.57M | — | — | — | 43 | 尚无授权文本 |
| CX CEMEX SAB DE CV | 2024-12-31 | 2/3 | — | $960M | — | — | — | 311 | 尚无授权文本 |
| KOF COCA COLA FEMSA SAB DE CV | 2024-12-31 | 2/3 | — | $24.55B | — | — | — | 115 | 尚无授权文本 |
| OMAB Central North Airport Group | 2024-12-31 | 2/3 | — | $4.94B | — | — | — | 205 | 尚无授权文本 |
| SBS COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP | 2024-12-31 | 2/3 | — | $9.58B | — | — | — | 403 | 尚无授权文本 |
| ACP abrdn Income Credit Strategies Fund | — | 0/3 | — | — | — | — | — | 7 | 尚无授权文本 |
| AEF abrdn Emerging Markets ex-China Fund, Inc. | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| AGD abrdn Global Dynamic Dividend Fund | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| AGMB Agomab Therapeutics NV | — | 0/3 | — | — | — | — | — | 6 | 尚无授权文本 |
| AOD abrdn Total Dynamic Dividend Fund | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| ASGI abrdn Global Infrastructure Income Fund | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| AWP abrdn Global Premier Properties Fund | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| BBN BlackRock Taxable Municipal Bond Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| BRW Saba Capital Income & Opportunities Fund | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| ENRD Einride AB | — | 0/3 | — | — | — | — | — | 5 | 尚无授权文本 |
| FAX ABRDN ASIA-PACIFIC INCOME FUND, INC. | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| GAB GABELLI EQUITY TRUST INC | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| GCV GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| GDV GABELLI DIVIDEND & INCOME TRUST | — | 0/3 | — | — | — | — | — | 5 | 尚无授权文本 |
| GGT GABELLI MULTIMEDIA TRUST INC. | — | 0/3 | — | — | — | — | — | 6 | 尚无授权文本 |
| GGZ Gabelli Global Small & Mid Cap Value Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| GLU GABELLI GLOBAL UTILITY & INCOME TRUST | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| GRX Gabelli Healthcare & WellnessRx Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| GUT GABELLI UTILITY TRUST | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| HQH abrdn Healthcare Investors | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| HQL abrdn Life Sciences Investors | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| IAF ABRDN AUSTRALIA EQUITY FUND, INC. | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| IFN ABERDEEN INDIA FUND, INC. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| JBK LEHMAN ABS CORP GOLDMAN SACHS CAP 1 SEC BACKED SER 2004-6 | — | 0/3 | — | — | — | — | — | 18 | 尚无授权文本 |
| LTGR Long Table Growth Corp. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| MFM ABERDEEN MUNICIPAL INCOME FUND | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| MGF ABERDEEN GOVERNMENT MARKETS INCOME FUND | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| MIN ABERDEEN INTERMEDIATE INCOME FUND | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| MMT ABERDEEN MULTI-MARKET INCOME FUND | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| NBB Nuveen Taxable Municipal Income Fund | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| NPFD Nuveen Variable Rate Preferred & Income Fund | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| PBLS Parabilis Medicines, Inc. | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| SABA Saba Capital Income & Opportunities Fund II | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| SBR SABINE ROYALTY TRUST | — | 0/3 | — | — | — | — | — | 100 | 尚无授权文本 |
| THQ abrdn Healthcare Opportunities Fund | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| THW abrdn World Healthcare Fund | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| USDE StableCoinX Inc. | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| VCRE Vicore Pharma Holding AB | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |